THE EFFECTS OF WITHDRAWAL OF TRIFLUOPERAZINE ON PATIENTS MAINTAINED ON THE COMBINATION OF TRANYLCYPROMINE AND  TRIFLUOPERAZINE: A DOUBLE-BLIND STUDY.
D001714:Bipolar Disorder; D003865:Major Depressive Disorder; D004311:Double-Blind Method; D001523:Mental Disorders; D011618:Psychotic Disorders; D012559:Schizophrenia; D014116:Toxicology; D014191:Tranylcypromine; D014268:Trifluoperazine
D014268:Trifluoperazine; D014191:Tranylcypromine
MENTAL DISORDERS; PSYCHOSES, INVOLUTIONAL; PSYCHOSES, MANIC-DEPRESSIVE; SCHIZOPHRENIA; TOXICOLOGIC REPORT; TRANYLCYPROMINE; TRIFLUOPERAZINE